Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

All Drugs Associated with Hepatic lesion (Page 2)

282 drugs have been associated with Hepatic lesion in FAERS reports.

Drug Reports Deaths Hosp. Life-Threat.
IMATINIB 31 1 5 1
PANTOPRAZOLE 31 2 8 1
INFLIXIMAB 30 0 14 2
AREDIA 29 7 19 0
CLONAZEPAM 29 0 24 0
LEDIPASVIR\SOFOSBUVIR 29 1 4 2
EPIRUBICIN 28 5 12 0
METFORMIN\SITAGLIPTIN 28 11 14 6
ROSUVASTATIN 28 0 16 6
ACETAMINOPHEN 26 6 14 0
IBRUTINIB 26 10 12 1
REGORAFENIB 26 7 2 0
SECUKINUMAB 26 1 14 2
IPILIMUMAB 25 0 16 0
PAZOPANIB 25 5 14 0
ETANERCEPT 24 1 14 4
MEPOLIZUMAB 23 4 16 4
SULFASALAZINE 23 0 13 2
APIXABAN 22 1 14 0
DABRAFENIB 22 3 5 1
IFOSFAMIDE 22 5 5 3
LANREOTIDE 22 4 8 1
SOFOSBUVIR 22 2 1 0
ALPELISIB 21 1 6 4
LENALIDOMIDE 21 4 9 1
TEMOZOLOMIDE 21 2 3 0
VENETOCLAX 21 6 9 3
LEFLUNOMIDE 20 0 12 2
ONDANSETRON 20 0 11 0
FINGOLIMOD 19 0 7 1
METFORMIN 19 0 15 10
MYCOPHENOLATE MOFETIL 19 4 12 7
PREDNISOLONE 19 10 8 5
ADO-TRASTUZUMAB EMTANSINE 18 0 2 0
CABOZANTINIB S-MALATE 18 1 3 0
CIPROFLOXACIN 18 5 8 5
LEUPROLIDE 18 7 8 1
LUTETIUM OXODOTREOTIDE LU-177 18 1 3 0
ALBUTEROL 17 0 13 0
GOSERELIN 17 0 2 0
LOSARTAN 17 0 11 8
RANITIDINE 17 9 7 0
RUXOLITINIB 17 7 10 1
SUNITINIB MALATE 17 6 7 0
USTEKINUMAB 17 0 9 0
CYCLOSPORINE 16 8 12 6
FLUDARABINE 16 11 11 5
NATALIZUMAB 16 0 5 0
SEMAGLUTIDE 16 12 1 0
VEDOLIZUMAB 16 0 11 0
« 1 2 3 4 5 6 »